EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece

Autor:	N Yfantopoulos, I Bafaloukos, J Yang, E Mintzia, P Ntontsi, A Skroumpelos, A Karokis
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S131
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.09.634
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8940078e55f43c377bba0c6bda95692b https://doi.org/10.1016/j.jval.2022.09.634 Zobrazit plný text záznamu Full Text from ScienceDirect